In vitro - og in vivo- forsøg har vist, at ritonavir i betydelig grad hæmmer CYP3A - og CYP2D6- medierede biotransformationer.
In vitro and in vivo studies have demonstrated that ritonavir is a potent inhibitor of CYP3A- and CYP2D6- mediated biotransformations.